🕵️ Aprea Therapeutics, Inc. ($APRE)
SEC insider & ownership activity, last 12 months · CIK 1781983 · every row links its SEC filing
Over the last 12 months insiders bought $211K with no open-market selling against it. Peters Richard bought $100K in discretionary trades (Mar). 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Jul 23, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $211K (14 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Peters Richard | 2 | $100K | 0 | – | Mar 31, 2026 |
| Gilad Oren | 4 | $50K | 0 | – | Jan 30, 2026 |
| John P. Hamill | 6 | $36K | 0 | – | Mar 31, 2026 |
| Duey Marc | 2 | $25K | 0 | – | Dec 10, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Soleus Private Equity Fund III, L.P. | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus Private Equity GP III, LLC | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus PE GP III, LLC | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus Capital, LLC | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus Capital Group, LLC | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus Capital Management, L.P. | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Soleus GP, LLC | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Guy Levy | 10.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Squadron Master Fund LP | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| Squadron Capital Management LLC | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| William Blank | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| Matthew Sesterhenn | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| Orin Hirschman | 9.9% | 13G | Apr 27, 2026 | filing ↗ | |
| AIGH Capital Management LLC | 9.9% | 13G | Apr 27, 2026 | filing ↗ | |
| Laurence W. Lytton | 9.9% | 13G | Nov 17, 2025 | filing ↗ | |
| Vestal Point Capital, LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Ryan Wilder | 9.9% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Jul 23, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Other events (8.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Other events (8.01) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 28, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 28, 2026 | filing ↗ |
| Other events (8.01) | Jan 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 28, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 23, 2026 | filing ↗ |
| Other events (8.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 8, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |